Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial

The results are an important advance for the treatment of melanoma, oncologists said, because patients lived significantly longer without their cancer returning.

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.bostonglobe.com)